“…For example, in earlier work from the present randomized community-based trial (N = 278), a community-delivered EBP for ADHD (Supporting Teens' Autonomy Daily [STAND]) was compared to UC. Treatment was delivered with suboptimal fidelity, EBP effect sizes were smaller than lab-based trials (Sibley et al, 2021a), and effects failed to separate from UC in both primary (ADHD symptoms and impairments; Sibley et al, 2021c) and secondary analyses (impact on comorbidities and nontargeted ADHDrelated outcomes like social skills and sluggish cognitive tempo; Sibley et al, 2023). However, in both primary and secondary analyses STAND demonstrated superiority to UC when therapists were licensed (ADHD symptoms, OTP skills, conduct problems; Sibley et al, 2021cSibley et al, , 2023.…”